Longevity Tech Fund

Longevity Tech Fund is a venture capital firm dedicated to investing in startups that aim to extend human healthspan through innovative technologies and therapies. The firm focuses on companies developing solutions in therapeutics, diagnostics, and data platforms that address age-related diseases and promote healthy aging. By supporting these ventures, Longevity Tech Fund seeks to contribute to the growing longevity economy, which reached $17 trillion in 2019 and is projected to reach $27 trillion by 2026. The firm's investment strategy targets early-stage companies, from pre-seed to Series A, that are based on validated science and have the potential for high impact. Longevity Tech Fund emphasizes a collaborative approach, co-investing with other leaders in the longevity field to support the industry's growth. The firm offers proactive portfolio support, including access to a network of scientists and investors, intellectual property and commercialization assistance, and exit opportunities. Through its investments, Longevity Tech Fund aims to drive innovation in the longevity sector, supporting the development of technologies that can significantly extend healthy human lifespan and improve quality of life for aging populations.

Qualified investors complying with Section § 272 of Act No. 240/2013 Coll., On Investment Companies and Investment Funds (ZISIF)